Volcano Corporation Announces Webcast Of March Seventh Analyst Day
SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, will hold its 2013 Analyst Day on Thursday, March 7, at the NASDAQ MarketSite in New York City.
A webcast of the event will begin at 10 a.m., Eastern Standard Time (7 a.m., Pacific Standard Time) and conclude at approximately 2 p.m., Eastern Standard Time (11 a.m., Pacific Standard Time). The webcast of the event will be available through Volcano's website on the webcasts and presentations page of the investor relations section at http://www.volcanocorp.com.
If you would like additional information about the event, please contact Neal Rosen at (650) 458-3014.
Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using light and sound as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company's website at www.volcanocorp.com.
SOURCE Volcano Corporation
More by this Source
Volcano Corporation Presentation At Goldman Sachs Conference To Be Webcast
Jun 05, 2013, 08:00 ET
Volcano stellt bei Präsentationsveranstaltung zu jüngsten klinischen Studien auf der EuroPCR 2013 vorläufige Ergebnisse der ADVISE-II-Studie vor und kündigt Aufnahme in SYNTAX2-Test an
May 24, 2013, 08:16 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.